Phase II trial of dasatinib for patients with acquired resistance to treatment with the epidermal growth factor receptor tyrosine kinase inhibitors erlotinib or gefitinib (Q35592279)
Jump to navigation
Jump to search
scientific article published on June 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II trial of dasatinib for patients with acquired resistance to treatment with the epidermal growth factor receptor tyrosine kinase inhibitors erlotinib or gefitinib |
scientific article published on June 2011 |
Statements
1 reference
Phase II trial of dasatinib for patients with acquired resistance to treatment with the epidermal growth factor receptor tyrosine kinase inhibitors erlotinib or gefitinib (English)
1 reference
William Pao
1 reference
Mark G Kris
1 reference
Camelia S Sima
1 reference
Melissa L Johnson
1 reference
Greg J Riely
1 reference
Naiyer A Rizvi
1 reference
Christopher G Azzoli
1 reference
Michelle S Ginsberg
1 reference
Vincent A Miller
1 reference
1 reference
Identifiers
1 reference